Cargando…

Anosmia during acute COVID-19 and psychiatric outcomes 4 months later: Results from the prospective COMEBAC cohort

Detalles Bibliográficos
Autores principales:	Faulet, Théo, Gasnier, Matthieu, Lecoq, Anne-Lise, Morin, Luc, Choucha, Walid, Montani, David, Monnet, Xavier, Becquemont, Laurent, Corruble, Emmanuelle, Colle, Romain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256631/ https://www.ncbi.nlm.nih.gov/pubmed/37328360 http://dx.doi.org/10.1016/j.genhosppsych.2023.06.003

Ejemplares similares

Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later
por: Gasnier, Matthieu, et al.
Publicado: (2022)

P124. Which Patients Will Have Mental Disorders After Hospitalization for COVID-19?
por: Gasnier, Matthieu, et al.
Publicado: (2022)

Psychiatric disorders and long COVID
por: Gasnier, Matthieu, et al.
Publicado: (2022)

128. Long Covid and Psychiatric Disorders 4 Months After a Hospitalization for COVID-19: A Cross Sectional Study
por: Gasnier, Matthieu, et al.
Publicado: (2023)

Intra-nasal Esketamine Induced Psychotic Disorder in a Post Covid-19 Major Depressive Episode: a case report
por: Tang, Julie, et al.
Publicado: (2023)

Post-acute COVID-19 syndrome
por: Montani, David, et al.
Publicado: (2022)

Syndrome post-COVID-19()
por: Montani, David, et al.
Publicado: (2023)

Functional respiratory complaints among COVID-19 survivors: a prospective cohort study
por: Beurnier, Antoine, et al.
Publicado: (2023)

The MAOA rs979605 Genetic Polymorphism Is Differentially Associated with Clinical Improvement Following Antidepressant Treatment between Male and Female Depressed Patients
por: Chappell, Kenneth, et al.
Publicado: (2022)

Human Dermal Fibroblast: A Promising Cellular Model to Study Biological Mechanisms of Major Depression and Antidepressant Drug Response
por: Mesdom, Pierre, et al.
Publicado: (2020)

Évaluation pluridisciplinaire des séquelles de COVID à 4 mois post-hospitalisation : analyse des données d’une large cohorte
por: Noel, N., et al.
Publicado: (2021)

The TRKB rs2289656 genetic polymorphism is associated with acute suicide attempts in depressed patients: A transversal case control study
por: Deflesselle, Eric, et al.
Publicado: (2018)

Liver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric Settings
por: Voican, Cosmin Sebastian, et al.
Publicado: (2016)

Telemedicine use during the COVID-19 lockdown is associated with fewer depressive symptoms among physicians in private practice
por: Frajerman, Ariel, et al.
Publicado: (2023)

Non-overweight depressed patients who respond to antidepressant treatment have a higher risk of later metabolic syndrome: findings from the METADAP cohort
por: El Asmar, K., et al.
Publicado: (2023)

Use of potentially driver-impairing drugs among older drivers
por: Zitoun, Sarah, et al.
Publicado: (2022)

Association between car driving and successful ageing. A cross sectional study on the "S.AGES" cohort
por: Baudouin, Edouard, et al.
Publicado: (2023)

The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age
por: Trabado, Séverine, et al.
Publicado: (2017)

Santé mentale des médecins libéraux français pendant la deuxième vague de COVID 19
por: Frajerman, Ariel, et al.
Publicado: (2023)

Blood microbiota and metabolomic signature of major depression before and after antidepressant treatment: a prospective case–control study
por: Ciocan, Dragos, et al.
Publicado: (2021)

The association of ARRB1 polymorphisms with response to antidepressant treatment in depressed patients
por: Chappell, Kenneth, et al.
Publicado: (2022)

Anosmia and ageusia
por: Tarakji, B., et al.
Publicado: (2020)

Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls
por: Montani, David, et al.
Publicado: (2021)

Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impulsivity: A Narrative Review
por: Nguyen, Thi Mai Loan, et al.
Publicado: (2023)

Neurobiological Approach of Catatonia and Treatment Perspectives
por: Ellul, Pierre, et al.
Publicado: (2015)

Olfaction and anosmia in rhinosinusitis
por: Dalton, Pamela
Publicado: (2004)

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle, Romain, et al.
Publicado: (2016)

Psychological distress among outpatient physicians in private practice linked to COVID-19 and related mental health during the second lockdown
por: Frajerman, Ariel, et al.
Publicado: (2022)

18. A case of anosmia
por: Zacharias, Hannah, et al.
Publicado: (2018)

Anosmia in COVID-19 patients
por: Hornuss, D., et al.
Publicado: (2020)

Features of anosmia in COVID-19
por: Klopfenstein, T., et al.
Publicado: (2020)

Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review
por: Jollant, Fabrice, et al.
Publicado: (2023)

Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion
por: Colle, Romain, et al.
Publicado: (2016)

Sequential change in olfaction and (non) motor symptoms: the difference between anosmia and non-anosmia in Parkinson’s disease
por: Fang, Ting-Chun, et al.
Publicado: (2023)

Can oxygen anosmia extend lifespan?
por: Abergel, Rachel, et al.
Publicado: (2017)

Association of COVID-19 with Anosmia and Hypogeusia
por: Nasir, Saad, et al.
Publicado: (2020)

COVID-19 and anosmia in Tehran, Iran
por: Gilani, Sapideh, et al.
Publicado: (2020)

67702 At-Home Screening Tool for Anosmia
por: Gupta, Shruti, et al.
Publicado: (2021)

Monitoring of cases of anosmia and COVID-19
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

The Effect of Topical Aminophylline on Hyposmia and Anosmia
por: Jahandideh, Hesam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4f3ib51qm8q8m09fbhnldolh1o